B6.129-Plod3tm1Soin/Oulu

Status

Available to order

EMMA IDEM:08330
Citation informationRRID:IMSR_EM:08330 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameB6.129-Plod3tm1Soin/Oulu
Alternative namePlod3tm1Soin
Strain typeTargeted Mutant Strains : Knock-out
Allele/Transgene symbolPlod3tm1Soin
Gene/Transgene symbolPlod3

Information from provider

ProviderRaija Soininen
Provider affiliationBiocenter Oulu, University of Oulu
Additional ownerProf. Johanna Myllyharju, University of Oulu, Faculty of Biochemistry and Molecular Medicine, Oulu, Finland
Genetic informationBeta galactosidase-PGK neo cassette inserted in-frame into exon 1 of the Plod3 gene.
Phenotypic informationHomozygous:
Homozygous embryos are developmentally retarded and fragile after E8.5 and die around E9.5-E10. At E9.5 in cells from homozygous embryos the basement membranes are fragmented, the endoplasmic reticulum is dilated, and the Golgi complexes and lysosomes are enlarged.

Heterozygous:
no changes observed
Breeding historyN=10 backcrosses
References
  • Premature aggregation of type IV collagen and early lethality in lysyl hydroxylase 3 null mice.;Rautavuoma Kati, Takaluoma Kati, Sormunen Raija, Myllyharju Johanna, Kivirikko Kari I, Soininen Raija, ;2004;Proceedings of the National Academy of Sciences of the United States of America;101;14120-5; 15377789
Homozygous fertileno
Homozygous viableno
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreUniversity of Oulu, Oulu, Finland
Animals used for archivingheterozygous C57BL/6JOlaHsd males

Disease and phenotype information

Orphanet associated rare diseases, based on orthologous gene matching

    • Connective tissue disorder due to lysyl hydroxylase-3 deficiency / Orphanet_300284
IMPC phenotypes (gene matching)
  • abnormal auditory brainstem response / IMPC
  • preweaning lethality, complete penetrance / IMPC
  • abnormal embryo size / IMPC
  • abnormal urinary bladder morphology / IMPC
  • abnormal pericardium morphology / IMPC
  • embryonic lethality prior to tooth bud stage / IMPC
  • embryonic growth retardation / IMPC
MGI phenotypes (allele matching)
  • abnormal cell morphology / MGI
  • decreased embryo size / MGI
  • embryonic growth retardation / MGI
  • abnormal preimplantation embryo development / MGI
  • embryonic lethality during organogenesis, complete penetrance / MGI
MGI phenotypes (gene matching)
  • cleft palate / MGI
  • abnormal cell morphology / MGI
  • exencephaly / MGI
  • abnormal lung morphology / MGI
  • blistering / MGI
  • abnormal epidermal layer morphology / MGI
  • decreased embryo size / MGI
  • intracranial hemorrhage / MGI
  • abnormal eye morphology / MGI
  • abnormal neural tube morphology / MGI
  • impaired basement membrane formation / MGI
  • abnormal Reichert's membrane morphology / MGI
  • embryonic growth retardation / MGI
  • abnormal skeleton morphology / MGI
  • increased vasodilation / MGI
  • abnormal vascular endothelial cell morphology / MGI
  • abnormal cutaneous collagen fibril morphology / MGI
  • abnormal preimplantation embryo development / MGI
  • neonatal lethality, complete penetrance / MGI
  • embryonic lethality during organogenesis, complete penetrance / MGI
  • prenatal lethality, incomplete penetrance / MGI
  • embryonic lethality during organogenesis, incomplete penetrance / MGI

Literature references

  • Premature aggregation of type IV collagen and early lethality in lysyl hydroxylase 3 null mice.;Rautavuoma Kati, Takaluoma Kati, Sormunen Raija, Myllyharju Johanna, Kivirikko Kari I, Soininen Raija, ;2004;Proceedings of the National Academy of Sciences of the United States of America;101;14120-5; 15377789

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740*
  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).